AQP9 and astrocytoma (excluding glioblastoma): On the contrary, AQP9 would promote astrocytoma cell invasion and motility 47 and its increase in mRNA-level was significantly correlated with aggressive progression and poor survival in clear cell renal cell carcinoma patients 48.